← Back
$GILD All transactions

GILEAD SCIENCES, INC.

▼ SELL 10b5-1 Plan

$ Value

$31K

Shares

200

Price

$156

Filed

Feb 18

Insider

Name

Mercier Johanna

Title

Chief Comm & Corp Aff Officer

CIK

0001782135

Roles

Officer

Transaction Details

Transaction Date

2026-02-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

120,288

Footnotes

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. | Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. | Sale prices for the transactions reported range from $154.57 to $155.27 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. | The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Filing Info

Accession No.

0001782135-26-000006

Form Type

4

Issuer CIK

0000882095

Mercier Johanna's History

Date Ticker Type Value
2026-02-27 GILD A $0
2026-02-17 GILD M $1.7M
2026-02-17 GILD $2.8M
2026-02-17 GILD $1.5M
2026-02-17 GILD $31K
2026-02-17 GILD M $0
2026-02-03 GILD A $0
2026-02-03 GILD F $3.6M
2026-01-15 GILD $373K
2025-12-15 GILD $366K

Other Insiders at GILD (90d)

Insider Bought Sold Last
Dickinson Andrew D
Chief Financial Officer
$463K 2026-02-27
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
$423K 2026-04-15
O'Day Daniel Patrick
Chairman & CEO
$37.2M 2026-03-27
Berger Dietmar
Chief Medical Officer
2026-02-27
Mercier Johanna
Chief Comm & Corp Aff Officer
$4.3M 2026-02-27
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
2026-02-27